The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in
the market. The vendor landscape section includes a market share analysis of major vendors along with
the competitive performances of their product portfolios. In addition, the report discusses the major
drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and
the market at large, as well as the key trends emerging in the market.
Technavio's report, Global Duchenne Muscular Dystrophy Drugs Market 2015-2019, has been prepared
based on an in-depth market analysis with inputs from industry experts. The report covers the Americas,
APAC, and EMEA; it also covers the landscape of the global Duchenne muscular dystrophy drugs market
and its growth prospects in the coming years. The report includes a discussion of the key vendors
operating in this market.
Key regions
Americas
APAC
EMEA
Browse Full Report With TOC @ http://www.radiantinsights.com/research/global-duchennemuscular-dystrophy-drugs-market-2015-2019
Key vendors
BioMarin Pharmaceutical
Eli Lilly
PTC Therapeutics
Santhera Pharmaceuticals
Sarepta Therapeutics
Other prominent vendors
Acceleron Pharma
Akashi Therapeutics
Asklepios BioPharmaceuticals
Bristol-Myers Squibb